Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats

Füllhase Claudius, Schreiber Andrea, Giese Armin, Schmidt Michael, Montorsi Francesco, Gratzke Christian, La Croce Giovanni, Castiglione Fabio, Stief Christian, Hedlund Petter

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims: To test if urodynamic effects from systemic Fatty Acid Amide Hydrolase (FAAH) inhibition involve sacral spinal cannabinoid type 1 (CB1) or type 2 (CB2) receptors. Methods: Male rats with or without partial urethral obstruction were used for cystometry or immunohistochemistry. Urodynamic effects of intravenous (IV) 0.3mg/kg Oleoyl Ethyl Amide (OEtA; FAAH inhibitor), and intrathecal (IT) 5μg rimonabant (CB1 antagonist) or 5μg SR144528 (CB2 antagonist) were studied in awake rats. Results: After administration of rimonabant or SR144528, non-obstructed rats with normal bladder function developed bladder overactivity (BO), which was counteracted by OEtA. OEtA also counteracted BO in obstructed rats. SR144528 did not affect bladder function in obstructed rats but counteracted the urodynamic effects of OEtA. Surprisingly, rimonabant (and AM251, another CB1 antagonist) reduced BO in obstructed rats, whereafter OEtA produced no additional urodynamic effects. CB1 expression increased in the sacral spinal cord of obstructed rats whereas no changes were observed for CB2 or FAAH. Conclusions: Urodynamic effects of systemic FAAH inhibition involve activities at spinal neuronal CB1 and CB2 receptors in normal and obstructed rats. Endogenous spinal CB receptor ligands seem to regulate normal micturition and BO. Altered spinal CB receptor functions may be involved in the pathogenesis of obstruction-induced BO.

Original languageEnglish
JournalNeurourology and Urodynamics
DOIs
Publication statusAccepted/In press - 2015

Fingerprint

Cannabinoid Receptors
Urodynamics
rimonabant
Urinary Bladder
Cannabinoid Receptor Antagonists
Cannabinoid Receptor CB2
Cannabinoids
Spinal Cord
Urethral Obstruction
fatty-acid amide hydrolase
Urination
Immunohistochemistry
Ligands

Keywords

  • AM251
  • Bladder
  • Endocannabinoid
  • Obstruction
  • Oleoyl ethyl amide
  • Overactivity
  • Rimonabant
  • SR144528

ASJC Scopus subject areas

  • Clinical Neurology
  • Urology

Cite this

Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats. / Claudius, Füllhase; Andrea, Schreiber; Armin, Giese; Michael, Schmidt; Francesco, Montorsi; Christian, Gratzke; Giovanni, La Croce; Fabio, Castiglione; Christian, Stief; Petter, Hedlund.

In: Neurourology and Urodynamics, 2015.

Research output: Contribution to journalArticle

Claudius, Füllhase ; Andrea, Schreiber ; Armin, Giese ; Michael, Schmidt ; Francesco, Montorsi ; Christian, Gratzke ; Giovanni, La Croce ; Fabio, Castiglione ; Christian, Stief ; Petter, Hedlund. / Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats. In: Neurourology and Urodynamics. 2015.
@article{3afa6bb560284dcb9f3324cada0674bc,
title = "Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats",
abstract = "Aims: To test if urodynamic effects from systemic Fatty Acid Amide Hydrolase (FAAH) inhibition involve sacral spinal cannabinoid type 1 (CB1) or type 2 (CB2) receptors. Methods: Male rats with or without partial urethral obstruction were used for cystometry or immunohistochemistry. Urodynamic effects of intravenous (IV) 0.3mg/kg Oleoyl Ethyl Amide (OEtA; FAAH inhibitor), and intrathecal (IT) 5μg rimonabant (CB1 antagonist) or 5μg SR144528 (CB2 antagonist) were studied in awake rats. Results: After administration of rimonabant or SR144528, non-obstructed rats with normal bladder function developed bladder overactivity (BO), which was counteracted by OEtA. OEtA also counteracted BO in obstructed rats. SR144528 did not affect bladder function in obstructed rats but counteracted the urodynamic effects of OEtA. Surprisingly, rimonabant (and AM251, another CB1 antagonist) reduced BO in obstructed rats, whereafter OEtA produced no additional urodynamic effects. CB1 expression increased in the sacral spinal cord of obstructed rats whereas no changes were observed for CB2 or FAAH. Conclusions: Urodynamic effects of systemic FAAH inhibition involve activities at spinal neuronal CB1 and CB2 receptors in normal and obstructed rats. Endogenous spinal CB receptor ligands seem to regulate normal micturition and BO. Altered spinal CB receptor functions may be involved in the pathogenesis of obstruction-induced BO.",
keywords = "AM251, Bladder, Endocannabinoid, Obstruction, Oleoyl ethyl amide, Overactivity, Rimonabant, SR144528",
author = "F{\"u}llhase Claudius and Schreiber Andrea and Giese Armin and Schmidt Michael and Montorsi Francesco and Gratzke Christian and Giovanni, {La Croce} and Castiglione Fabio and Stief Christian and Hedlund Petter",
year = "2015",
doi = "10.1002/nau.22753",
language = "English",
journal = "Neurourology and Urodynamics",
issn = "0733-2467",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats

AU - Claudius, Füllhase

AU - Andrea, Schreiber

AU - Armin, Giese

AU - Michael, Schmidt

AU - Francesco, Montorsi

AU - Christian, Gratzke

AU - Giovanni, La Croce

AU - Fabio, Castiglione

AU - Christian, Stief

AU - Petter, Hedlund

PY - 2015

Y1 - 2015

N2 - Aims: To test if urodynamic effects from systemic Fatty Acid Amide Hydrolase (FAAH) inhibition involve sacral spinal cannabinoid type 1 (CB1) or type 2 (CB2) receptors. Methods: Male rats with or without partial urethral obstruction were used for cystometry or immunohistochemistry. Urodynamic effects of intravenous (IV) 0.3mg/kg Oleoyl Ethyl Amide (OEtA; FAAH inhibitor), and intrathecal (IT) 5μg rimonabant (CB1 antagonist) or 5μg SR144528 (CB2 antagonist) were studied in awake rats. Results: After administration of rimonabant or SR144528, non-obstructed rats with normal bladder function developed bladder overactivity (BO), which was counteracted by OEtA. OEtA also counteracted BO in obstructed rats. SR144528 did not affect bladder function in obstructed rats but counteracted the urodynamic effects of OEtA. Surprisingly, rimonabant (and AM251, another CB1 antagonist) reduced BO in obstructed rats, whereafter OEtA produced no additional urodynamic effects. CB1 expression increased in the sacral spinal cord of obstructed rats whereas no changes were observed for CB2 or FAAH. Conclusions: Urodynamic effects of systemic FAAH inhibition involve activities at spinal neuronal CB1 and CB2 receptors in normal and obstructed rats. Endogenous spinal CB receptor ligands seem to regulate normal micturition and BO. Altered spinal CB receptor functions may be involved in the pathogenesis of obstruction-induced BO.

AB - Aims: To test if urodynamic effects from systemic Fatty Acid Amide Hydrolase (FAAH) inhibition involve sacral spinal cannabinoid type 1 (CB1) or type 2 (CB2) receptors. Methods: Male rats with or without partial urethral obstruction were used for cystometry or immunohistochemistry. Urodynamic effects of intravenous (IV) 0.3mg/kg Oleoyl Ethyl Amide (OEtA; FAAH inhibitor), and intrathecal (IT) 5μg rimonabant (CB1 antagonist) or 5μg SR144528 (CB2 antagonist) were studied in awake rats. Results: After administration of rimonabant or SR144528, non-obstructed rats with normal bladder function developed bladder overactivity (BO), which was counteracted by OEtA. OEtA also counteracted BO in obstructed rats. SR144528 did not affect bladder function in obstructed rats but counteracted the urodynamic effects of OEtA. Surprisingly, rimonabant (and AM251, another CB1 antagonist) reduced BO in obstructed rats, whereafter OEtA produced no additional urodynamic effects. CB1 expression increased in the sacral spinal cord of obstructed rats whereas no changes were observed for CB2 or FAAH. Conclusions: Urodynamic effects of systemic FAAH inhibition involve activities at spinal neuronal CB1 and CB2 receptors in normal and obstructed rats. Endogenous spinal CB receptor ligands seem to regulate normal micturition and BO. Altered spinal CB receptor functions may be involved in the pathogenesis of obstruction-induced BO.

KW - AM251

KW - Bladder

KW - Endocannabinoid

KW - Obstruction

KW - Oleoyl ethyl amide

KW - Overactivity

KW - Rimonabant

KW - SR144528

UR - http://www.scopus.com/inward/record.url?scp=84925252397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925252397&partnerID=8YFLogxK

U2 - 10.1002/nau.22753

DO - 10.1002/nau.22753

M3 - Article

AN - SCOPUS:84925252397

JO - Neurourology and Urodynamics

JF - Neurourology and Urodynamics

SN - 0733-2467

ER -